Figure 1
From: Clinical implications of cytogenetic heterogeneity in multiple myeloma patients with TP53 deletion
Study design: subgroups defined by chromosome and/or FISH analysis.
Figure 1 | Modern Pathology
From: Clinical implications of cytogenetic heterogeneity in multiple myeloma patients with TP53 deletion
Study design: subgroups defined by chromosome and/or FISH analysis.
